To synthesize recombinant human insulin, synthetic oligonucleotides encoding the insulin A and B chains are inserted into a plasmid together with an an antibiotic resistance gene and the E. coli lacZ gene and its promoter to yield an expression vector.
The recombinant plasmids are transferred to E. coli hosts, where β-galactosidase/insulin fusion proteins are produced.